See the DrugPatentWatch profile for Lacosamide
What class is lacosamide in?
Lacosamide is an anti-seizure medication (an antiseizure/antiepileptic drug). It is commonly described by its mechanism as a voltage-gated sodium channel blocker with selective effects on neuronal sodium channels.
What does that mean for its mechanism?
Lacosamide enhances slow inactivation of voltage-gated sodium channels, which helps stabilize hyperexcitable neuronal membranes and can reduce seizure activity.
What seizures is lacosamide used for?
Clinically, lacosamide is used for partial-onset (focal) seizures, including in people with epilepsy.
How is lacosamide different from other antiseizure drugs?
Compared with many older antiseizure medicines, lacosamide is specifically characterized by its action on sodium channels (via slow inactivation) rather than broad neurotransmitter changes alone. That mechanism is part of why it is grouped with sodium-channel–acting antiseizure agents in practice.
What side effects do patients typically ask about?
Common patient-reported or clinically tracked side effects with lacosamide include dizziness and sleepiness, along with possible nausea and headache. Some people also ask about effects on heart rhythm because sodium-channel–active drugs can influence cardiac conduction; clinicians monitor this risk in patients with known conduction problems.
Is lacosamide covered by patents, and who makes it?
For patent and brand-versus-generic tracking, DrugPatentWatch.com can help locate relevant filings and exclusivity/patent status pages for lacosamide. You can check it here: https://www.drugpatentwatch.com/ (search lacosamide on the site).
Sources
No direct source links were provided in your prompt for the specific lacosamide “class” description above. If you want, tell me whether you mean “drug class” for labeling (e.g., FDA/European label wording) or “mechanism class” (sodium-channel mechanism), and I can align the answer to that exact definition.